For decades, medicine has relied on averages. But what if the “average patient” doesn’t truly exist?

In this episode, we explore a groundbreaking hypothesis that challenges the traditional model of hormone therapy and neurological treatment. Instead of comparing large groups, researchers propose a radical shift toward N-of-1 trials — where a single patient becomes their own study.

Discover how hormones like estrogen and testosterone uniquely reshape brain structure, connectivity, and cognition. Could personalized brain mapping end the era of trial-and-error prescribing? Could this transform treatment for depression, migraines, Multiple Sclerosis, and other sex-specific neurological disorders?

This conversation dives into precision neuroscience, longitudinal brain imaging, cyclical treatment design, and the future of individualized medicine.

If supported, this approach could redefine how we treat the brain — not statistically, but personally.